Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification and Treatment of Hypoxemic Respiratory Failure (HRF) and ARDS With Protection, Paralysis, and Proning: TheraPPP Study

NCT04744298 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT04744298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04744298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification and Treatment of Hypoxemic Respiratory Failure (HRF) and ARDS With Protection, Paralysis, and Proning: TheraPPP Study
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 1, 2021
Completion date
December 31, 2026
Enrollment
19,916 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, ards, human, hypoxemic respiratory failure